QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
Log in
NASDAQ:DNLI

Denali Therapeutics Earnings Date, Estimates & History

$63.00
-3.76 (-5.63 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$62.20
Now: $63.00
$67.66
50-Day Range
$62.81
MA: $71.84
$81.53
52-Week Range
$12.39
Now: $63.00
$93.94
Volume560,973 shs
Average Volume646,906 shs
Market Capitalization$7.55 billion
P/E RatioN/A
Dividend YieldN/A
Beta2

Earnings

Denali Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 25th, 2021 based off prior year's report dates.

Denali Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Denali Therapeutics (NASDAQ:DNLI) Earnings Estimates

2021 EPS Consensus Estimate: ($2.55)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.68)($0.50)($0.59)
Q2 20212($0.71)($0.52)($0.62)
Q3 20212($0.75)($0.68)($0.72)
Q4 20212($0.78)($0.48)($0.63)

Denali Therapeutics (NASDAQ DNLI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/25/2021
(Estimated)
 ($0.09)    
11/5/20209/30/2020$4.19($0.54)($0.54)$564.69 million$9.39 millionListen
8/7/20206/30/2020($0.61)($0.56)($0.56)$3.71 million$5.85 millionN/A
5/7/20203/31/2020($0.57)($0.55)($0.55)$5.93 million$3.60 millionN/A
2/27/202012/31/2019($0.58)($0.56)($0.56)$15.71 million$4.67 millionN/A
11/6/2019Q3($0.5630)($0.48)($0.48)$10.86 million$13.60 millionN/A
8/6/2019Q2 2019($0.46)($0.61)($0.61)$4.52 million$4.20 millionN/A
5/8/2019Q1($0.4030)($0.41)($0.41)$12.88 million$4.21 millionN/A
3/12/201912/31/2018($0.11)$0.79$0.79$9.73 million$125.68 millionN/A
11/8/2018Q3($0.2530)($0.38)($0.38)$3.00 million$1.20 millionN/A
8/9/2018Q2 2018($0.2030)($0.59)($0.59)$3.00 million$1.65 millionN/A
5/11/2018Q1 2018$0.13($0.26)($0.26)$45.00 million$0.64 millionN/A
3/19/2018Q4 2017($0.2720)($0.74)($0.74)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.